Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

NCT04584242 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Interventions

DRUG: gluconon tab 15mg
DRUG: suganon tab 5mg

Sponsor

Yonsei University